Literature DB >> 23745196

Treatment of recurrent breast cancer following breast conserving surgery.

Amy E E Burger1, Simon J Pain, Gabor Peley.   

Abstract

Patients with isolated ipsilateral breast cancer recurrence face completion mastectomy in the majority of cases. Selected patients may derive good outcomes from repeat breast conservation surgery and indeed repeat irradiation may be employed using one of many different modalities. Tumor biology rather than salvage surgery method is likely to influence outcome. Patients with isolated breast tumor recurrence are treated in the majority of cases with completion mastectomy, when for selected patients there exists little evidence that more radical surgery provides better outcomes in terms of further recurrence and overall survival, than repeated breast conserving surgery. Literature search identifying articles addressing the issue of repeat breast conserving surgery for ipsilateral breast tumor recurrence, and repeat radiotherapy(search terms include: repeat breast conserving surgery, salvage mastectomy, salvage breast conserving surgery,salvage radiotherapy, reirradiation). Thirty-five articles discussed the outcomes of repeat breast conserving surgery versus salvage mastectomy, methods of repeat breast irradiation, repeat sentinel lymph node biopsy and related factors. Repeat breast conserving surgery may represent a safe and feasible treatment method for isolated ipsilateral breast tumor recurrence.

Entities:  

Mesh:

Year:  2013        PMID: 23745196     DOI: 10.1111/tbj.12105

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  7 in total

1.  Adjuvant intraoperative radiotherapy for selected breast cancers in previously irradiated women: Evidence for excellent feasibility and favorable outcomes.

Authors:  Gladys Blandino; Marina Guenzi; Liliana Belgioia; Elisabetta Bonzano; Elena Configliacco; Elena Tornari; Francesca Cavagnetto; Davide Bosetti; Alessandra Fozza; Daniele Friedman; Renzo Corvò
Journal:  Rep Pract Oncol Radiother       Date:  2017-05-05

2.  Successful treatment of accessory breast cancer with endocrine therapy.

Authors:  Chun-Xi Wang; Shu-Li Guo; Li-Na Han
Journal:  J Zhejiang Univ Sci B       Date:  2017 Jan.       Impact factor: 3.066

3.  Increased Mortality with Repeat Lumpectomy Alone After Ipsilateral Breast Tumor Recurrence.

Authors:  Yonghui Su; Rong Guo; Jingyan Xue; Yayun Chi; Weiru Chi; Jia Wang; Benglong Yang; Jiong Wu
Journal:  Oncologist       Date:  2019-03-06

4.  High-dose-rate Brachytherapy as Adjuvant Local rEirradiation for Salvage Treatment of Recurrent breAst cancer (BALESTRA): a retrospective mono-institutional study.

Authors:  Andrea Vavassori; Giulia Riva; Iacopo Cavallo; Ruggero Spoto; Samantha Dicuonzo; Cristiana Fodor; Stefania Comi; Raffaella Cambria; Federica Cattani; Anna Morra; Maria Cristina Leonardi; Roberta Lazzari; Mattia Intra; Alberto Luini; Viviana Enrica Galimberti; Paolo Veronesi; Roberto Orecchia; Barbara Alicja Jereczek-Fossa
Journal:  J Contemp Brachytherapy       Date:  2020-06-30

5.  Repeat Breast-Conserving Surgery Versus Salvage Mastectomy for Ipsilateral Breast Tumour Recurrence After Breast-Conserving Surgery in Breast Cancer Patients: A Meta-Analysis.

Authors:  Caiqin Mo; Weihong Ruan; Junyu Lin; Huaying Chen; Xiangjin Chen
Journal:  Front Oncol       Date:  2021-11-23       Impact factor: 6.244

6.  Sub-Muscular Direct-to-Implant Immediate Breast Reconstruction in Previously Irradiated Patients Avoiding the Use of ADM: A Preliminary Study.

Authors:  Lucrezia Pacchioni; Gianluca Sapino; Irene Laura Lusetti; Giovanna Zaccaria; Pietro G Di Summa; Giorgio De Santis
Journal:  J Clin Med       Date:  2022-10-03       Impact factor: 4.964

7.  Breast-conserving surgery with intraoperative radiotherapy in recurrent breast cancer: the patient's perspective.

Authors:  Constanze Elfgen; U Güth; G Gruber; S Birrer; V Bjelic-Radisic; M Fleisch; C J Tausch
Journal:  Breast Cancer       Date:  2020-06-01       Impact factor: 4.239

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.